Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Basagine pharmacokinetic study in healthy local volunteers
IRCT201203227978N2Phase 4Completed
- Sponsor
- Getz Pharma
- Start
- Jun 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, single-arm trial of insulin glargine in diabetes mellitus (DM), sponsored by Getz Pharma. Primary endpoint: Pharmacokinetic behavior of Basagine. Started Jun 2012; status: completed.
02
Drugs
insulin glargine
03
Conditions
diabetes mellitus (DM)
Beyond the preview
Go deeper on IRCT201203227978N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201203227978N2.